PTPA and cancer: Here, we will review and discuss the mechanisms that bias PP2A holoenzyme assembly in human cancer and how recent research has shown that small molecules can be used to stabilize or inhibit specific PP2A holoenzymes as a potential therapeutic strategy for the treatment of a diverse range of cancers.